dipyridamole has been researched along with eicosapentaenoic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gordge, MP; Neild, GH; Rylance, PB | 1 |
| Ablett, MB; Ilsley, CD; Nye, ER; Robertson, MC; Sutherland, WH | 1 |
| Campbell, WB; Dehmer, GJ; Eichhorn, EJ; Jennings, L; Popma, JJ; Prewitt, JB; Schmitz, JM; van den Berg, EK; Willerson, JT | 1 |
| Cameron, CA; Landymore, RW; MacAuley, MA; Sheridan, BL | 1 |
| Abe, F; Abe, K; Ito, S; Omata, K; Yamada, M | 1 |
2 trial(s) available for dipyridamole and eicosapentaenoic acid
| Article | Year |
|---|---|
Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Lipids; Male; Middle Aged; Postoperative Care; Recurrence | 1990 |
Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids.
Topics: Angioplasty, Balloon; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Coronary Vessels; Diet; Dipyridamole; Eicosapentaenoic Acid; Fatty Acids; Humans; Male; Middle Aged; Random Allocation; Recurrence; Time Factors | 1988 |
4 other study(ies) available for dipyridamole and eicosapentaenoic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
Topics: Aspirin; Blood Pressure; Creatinine; Diabetic Nephropathies; Dipyridamole; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fish Oils; Glomerular Filtration Rate; Hemostasis; Humans; Hypertension; Kidney Failure, Chronic; Male; Platelet Aggregation Inhibitors; Proteinuria | 1992 |
Reduction of intimal hyperplasia in canine autologous vein grafts with cod-liver oil and dipyridamole.
Topics: Animals; Blood Coagulation Tests; Cholesterol, Dietary; Cod Liver Oil; Dipyridamole; Dogs; Eicosapentaenoic Acid; Femoral Artery; Fish Oils; Hyperplasia; Jugular Veins; Partial Thromboplastin Time; Platelet Count; Postoperative Complications; Prothrombin Time; Veins | 1986 |
Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia.
Topics: Aspirin; Dinoprost; Dipyridamole; Eicosapentaenoic Acid; Epoprostenol; Humans; Hyperlipidemias; Hypertension; Platelet Aggregation Inhibitors; Thromboxane A2; Ticlopidine | 1999 |